SCHEMBL20002879

SCHEMBL20002879

CC1CCN(C(=O)N2CCC(Sc3ccc(F)cc3)C2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 5/20 0.43
HPGD P15428 4/20 0.41
KMT2A Q03164 3/20 0.41
LMNA P02545 2/20 0.41
MAPK1 P28482 1/20 0.41
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 1/20 0.40
CHRM2 P08172 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
DRD1 P21728 1/20 0.40
ADRA1A P35348 1/20 0.40
OPRM1 P35372 1/20 0.40
DRD3 P35462 1/20 0.40
KCNH2 Q12809 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
ACHE P22303 1/20 0.38
CCR5 P51681 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20002407 0.88 SMN1; SMN2 (0.41) NPC1RAB9ASMN1; SMN2KMT2ALMNA
SCHEMBL20002936 0.88 CCR5 (0.46) SMN1; SMN2KMT2AKCNH2CCR5GRIN1
SCHEMBL20002297 0.86 NOTUM (0.47) NPC1RAB9AKMT2ACCR5GRIN1
SCHEMBL20002294 0.84 PTPN11 (0.36) KMT2AMAPK1CHRM2CCR5GRIN1
SCHEMBL20002612 0.83 RORC (0.36) NPC1RAB9AKMT2ACCR5GRIN1
SCHEMBL20003024 0.83 NOTUM (0.44) NPC1RAB9AKMT2AALDH1A1MEN1
SCHEMBL20002136 0.78 GPR119 (0.49) KMT2AMEN1
SCHEMBL20003048 0.77 PDK1 (0.41) RAB9ASMN1; SMN2KMT2ALMNAALDH1A1
SCHEMBL20002992 0.77 PDK1 (0.41) RAB9ASMN1; SMN2KMT2ALMNAALDH1A1
SCHEMBL20002255 0.77 CCR5 (0.49) KMT2ACCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3092229-B1 PYRROLIDINYL SULFONE DERIVATIVES AND THEIR USE AS ROR GAMMA MODULATORS BRISTOL MYERS SQUIBB CO (US) 2018-03-28 EP disclosed